izontal surfaces in the rooms of patients with C. difficile infection.
It would be obtuse to assume that in vitro experiments precisely simulate in vivo conditions. Similarly, relying solely on an antimicrobial agent's minimum inhibitory concentration to predict its clinical efficacy against a particular infecting pathogen is ill-advised. Thus, it is standard practice to employ in vitro models of infection to simulate, among other factors, waning concentrations of an antimicrobial agent after each dose is administered. The impact of cleaning and disinfecting agents should be viewed no differently. Initial working strength concentrations applied to surfaces do, in fact, wane over time. Subsequently, in germicides and/or cleaning agents, the residual active components are exposed to organic material (eg, feces containing C. difficile in both vegetative and spore forms). If working strength concentrations were universally delivered after their initial application, it would be surprising if the environment was ever implicated in the spread of infection. We caution against assuming that use of a germicide or a cleaning agent guarantees effective environmental decontamination; it does not. Thus, it has been shown that as the level of environmental contamination with C. difficile increases, so does the magnitude of healthcare worker hand contamination. 3 In our article, 2 we acknowledged that the clinical significance of results showing an increased rate of sporulation associated with use of some cleaning agents and/or germicides is unknown. However, as pointed out by Holtschlag, 1 the US Enironmental Protection Agency does not currently recognize a test method for inactivation of C. difficile spores. It is logical, therefore, to use different test methodologies and to base any conclusions concerning the potential efficacy of agents against C. difficile on all of the results obtained. This is what we did. It would be unwise to pick and choose which results appear more favorable, particularly, as in Holtschlag's case, if there is a potential conflict of interest. Hence, we concluded our report by stating that "the combined body of evidence suggests that dichloroisocyanurate (ie, chlorine-release) germicides currently represent the optimum choice for the removal of C. difficile from healthcare environments." 2<p924) We went on to say that our results "suggest that compounds that do not kill C. difficile spores at working concentrations, such as general-purpose detergents and hydrogen peroxide, may promote the persistence and accumulation of spores in healthcare environments." 2(p924) We stand by these comments.
Should Test Methods for Disinfectants
Use Vertebrate Viruses Dried on Carriers to Advance Virucidal Claims?
TO T H E E D I T O R -The advancements made in microbicidal science in the past decade have raised questions about the appropriateness of the test methods still being used to substantiate microbicidal and virucidal claims globally. The test methods currently being used to evaluate the virucidal activity of disinfectants employ challenge virus that is either dried on prototypical hard surfaces or is in suspension. The latter approach presents a weaker challenge to the formulation that is being tested. 1,2 Regulatory agencies such as the US Environmental Protection Agency, Canadian General Standard Board, and Australian Therapeutic Goods Administration require that data for virucidal activity be based on carrier test methods that use vertebrate viruses.
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the virucidal activity of disinfectants. A number of our carrier test methods have been approved by the US Environmental Protection Agency to generate virucidal data for product registration. 3 Such virucidal data are also accepted by the Canadian General Standard Board, the Australian Therapeutic Goods Administration, and jurisdictions in Asian countries. Vertebrate viruses (nor bacteriophages) on naturally contaminated environmental surfaces pose a danger to public health. Disinfectants with demonstrated virucidal activity against these pathogenic viruses play a pivotal role in the interruption of viral dissemination through such vehicles. Experts believe that the ideal disinfectant should be effective against both gram-positive and gram-negative bacteria, as well as pathogenic viruses, when tested using carrier-based methods. The scientific literature strongly supports the idea that data generated using relevant vertebrate viruses, such as enteric viruses (coronavirus and rotavirus) or respiratory viruses (influenzaviruses and rhinovirus), are relevant to real-life situations and should be considered when relevant virucidal claims are issued. It is, therefore, of paramount importance to consider the following factors in the evaluation of a product registration that includes claims about virucidal activity: (1) Vertebrate viruses (not bacteriophages) are emerging and/or reemerging pathogens of public health concern. (2) Vertebrate viruses survive on contaminated environmental surfaces, which may play a role in the dissemination of an infectious virus. (3) 2005, which both require virucidal testing against only bacteriophages or nonenveloped vertebrate viruses, will eliminate many disinfectants otherwise effective against emerging and reemerging viruses. (6) Regulatory agencies worldwide (in the United States, Canada, Australia, and Asian countries) accept data on the efficacy of virucidal agents that are generated using vertebrate viruses (enveloped and naked or nonenveloped viruses). This is in line with the demand by both consumers and the infection control community to know the virucidal efficacy of the products that are being used against emerging and/or reemerging pathogens, such as severe acute respiratory syndrome-associated human coronavirus, avian influenza virus, and, more recently, rabies in China and batborne Melaka virus, a type of reovirus, in Malaysia. (7) Public health agencies, such as the Centers for Disease Control and Prevention and the World Health Organization, issue public advisories on emerging pathogens based on the claims of virucidal activity against vertebrate viruses that are being made for registered products.
Therefore, it is scientifically justifiable to use vertebrate viruses (enveloped or nonenveloped viruses) to generate data on the efficacy of virucidal agents for the purpose of making relevant virucidal claims, given that these data add weight to a virucidal claim and generate greater confidence about that claim in the minds of the infection control community and the public at large (Figure) . Emerging and reemerging viruses and their sensitivities to microbicides. SARS-HCoV, severe acute respiratory syndromeassociated human coronavirus; SV40, simian virus 40.
